Efficacy of Platelet Rich Plasma in Plantar Fasciitis

Plantar Fascitis Clinical Trial

— APOPLANT  

Official title:

Plantar Fasciitis Treatment: Double Blinded Randomized Control Study of the Efficacy of an Injection of Platelet Rich Plasma (PRP) Versus an Infiltration of Corticosteroids

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03857334
• Other study ID #: UF 8737
• Status: Completed
• Phase: N/A
• Start date: July 1, 2016
• Est. completion date: December 31, 2018

Study information

• Verified date: February 2019
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Plantar fasciitis is a common pathology among podiatry moreover the healing time takes several months.

The main aim of this study is to evaluate the efficacy of a injection of Platelet-Rich Plasma (PRP) versus corticosteroid injection.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: December 31, 2018
• Est. primary completion date: October 18, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Plantar fasciitis

• Average VAS greater than or equal to 5/10

• Resistance of medical reference treatment

Exclusion Criteria:

• Other plantar lesion find on RMI

• Pregnancy

Related Conditions & MeSH terms

• Fasciitis
• Fasciitis, Plantar
• Plantar Fascitis

Intervention

Biological:
• Injection of autologous platelet rich plasma

Drug:
• Injection of cortivazol : Altim®
Corticosteroids

Locations

Country	Name	City	State
France	Montpellier University Hosîtal	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mean daily pain measured with a visual analog scale from 0 to 10	Comparison of pain intensity, measured with a visual analog scale from 0 to 10	6 months
Secondary	Pain intensity during the first steps of the day measured with a visual analog scale from 0 to 10	Measured with a visual analog scale from 0 to 10	6 months
Secondary	Pain intensity on direct compression measured with a visual analog scale from 0 to 10	Constant intensity of the compression, measured with a visual analog scale from 0 to 10	6 months
Secondary	Impairment of walking function	Foot function index	6 months